Metraipolis › archive › dc_2728dfd08aa9

Assessment of the PD-1/PD-L1/PD-L2 Immune Checkpoints Pathway in Endometrial Cancer and Its Clinical Significance — Europe PMC PMID:41228278

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41228278
DOI: 10.3390/cancers17213485
License (as archived): solo-consultazione
Archived: 2026-11-08T23:12:35.433Z
SHA-256 of the archived text: c4e3d1bc63c179c2ac5278e131100b885b35da5c95cb9cecefdcbd34a86c1fc6
Stable URL of this page: https://metraipolis.com/documento/dc_2728dfd08aa9

How to cite

Assessment of the PD-1/PD-L1/PD-L2 Immune Checkpoints Pathway in Endometrial Cancer and Its Clinical Significance — Europe PMC PMID:41228278 — Europe PMC (en), https://europepmc.org/article/MED/41228278 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2728dfd08aa9 (Metraipolis archive dc_2728dfd08aa9, sha256 c4e3d1bc63c179c2ac5278e131100b885b35da5c95cb9cecefdcbd34a86c1fc6)

BibTeX

@misc{dc2728dfd08aa9,
  title = {Assessment of the PD-1/PD-L1/PD-L2 Immune Checkpoints Pathway in Endometrial Cancer and Its Clinical Significance — Europe PMC PMID:41228278},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41228278},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2728dfd08aa9; sha256 c4e3d1bc63c179c2ac5278e131100b885b35da5c95cb9cecefdcbd34a86c1fc6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41228278. Agents can read the archived copy with the MCP tool read_document.